Scholarlink

To better understand the impact of COVID-19 and its complicated disease process, this chapter will first describe the underlying pathobiological mechanisms of COVID-19 coagulopathy. Second, there will be a review of the information on the incidence of VTE and bleeding in patients with COVID-19 and a summarization of the initial consensus recommendations about antithrombotic prophylaxis. Third, the results of trials that evaluated the efficacy and safety of antithrombotic agents for patients with COVID-19 and integrated this information into practical recommendations. Finally, the chapter provides a summary of VTE events after vaccinations against SARS-COV-2, including the phenomenon of vaccination induced thrombotic thrombocytopenia (VITT).

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

COVID-19 VTE Prophylaxis: ICU, Wards, and Discharge

  • 动态工具书词条

  • 发表日期：

    2025年

查看全文
  • Behnood Bikdeli,
  • David Jiménez

摘要

To better understand the impact of COVID-19 and its complicated disease process, this chapter will first describe the underlying pathobiological mechanisms of COVID-19 coagulopathy. Second, there will be a review of the information on the incidence of VTE and bleeding in patients with COVID-19 and a summarization of the initial consensus recommendations about antithrombotic prophylaxis. Third, the results of trials that evaluated the efficacy and safety of antithrombotic agents for patients with COVID-19 and integrated this information into practical recommendations. Finally, the chapter provides a summary of VTE events after vaccinations against SARS-COV-2, including the phenomenon of vaccination induced thrombotic thrombocytopenia (VITT).